In contrast, augmentation of type I IFN (IFN-β) signaling in inflammatory CNS diseases such as multiple sclerosis blocked excess type II IFN (IFN-γ) signaling, CD4 T regulatory cell suppression and leukocyte infiltration62,64,65. This evidence concerns the gene IFNB1 and multiple sclerosis.